https://european-biotechnology.net/wp-content/uploads/2025/09/GenfitHQ_MAES-AREA-Englos-e1758436555810.jpg507900Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-21 06:46:572025-09-23 09:32:03Genfit SA discontinues lead programme
https://european-biotechnology.net/wp-content/uploads/2025/09/Protein_PTPN2_PDB_1l8k-e1758293740711-1030x580-1.png5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-19 14:56:192025-09-25 10:02:02Mondego Bio kicks off with Series A financing
https://european-biotechnology.net/wp-content/uploads/2025/09/Monte-Rosa-Therapeutics-team-buidling-e1758007966532-1030x580-1.jpg5801030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-16 07:33:452025-09-16 07:33:45Monte Rosa Therapeutics and Novartis agree on second billion-dollar deal
https://european-biotechnology.net/wp-content/uploads/2025/09/UK-ABPI_1413460705_tg-e1757836939756.jpg477953Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-12 12:47:032025-09-12 12:47:03UK pharma lobby warns of crisis in British life sciences
